연구성과로 돌아가기

2021 연구성과 (167 / 281)

※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
WoS SCOPUS Document Type Document Title Abstract Authors Affiliation ResearcherID (WoS) AuthorsID (SCOPUS) Author Email(s) Journal Name JCR Abbreviation ISSN eISSN Volume Issue WoS Edition WoS Category JCR Year IF JCR (%) FWCI FWCI Update Date WoS Citation SCOPUS Citation Keywords (WoS) KeywordsPlus (WoS) Keywords (SCOPUS) KeywordsPlus (SCOPUS) Language Publication Stage Publication Year Publication Date DOI JCR Link DOI Link WOS Link SCOPUS Link
Article Tailoring the bandgap, magnetic and photocatalytic behavior of CdS:Nd nanoparticles We report the fabrication of CdS:Nd nanoparticles (NPs) via an economical co-precipitation method, giving adjustable optical, magnetic and photocatalytic behavior of the nanocrystalline CdS by varying the Nd ion doping concentration. The sensible doping of Nd ions into the CdS matrix was confirmed by various structural characterization techniques. Transmission electron microscopy images demonstrated the basic spheroid shape of the nanoparticles, with sizes in the range of 8-10 nm. A doping concentration-dependent redshift was observed in the CdS NP spectra, resulting from the decrease in the bandgap. The M-H curves illustrate that the undoped sample is diamagnetic, the 2 at% Nd sample is ferromagnetic, and the 4 at% Nd sample is superparamagnetic at room temperature. Photocatalytic measurements revealed that the CdS:Nd (4 at%) sample displayed better photocatalytic activity than undoped CdS NPs. As per literature, this could be the first report on the CdS:Nd system and we believed that it will be more beneficial for the further research on the CdS:Nd system. Poornaprakash, B.; Vattikuti, S. V. Prabhakar; Kim, Y. L.; Reddy, M. Siva Pratap; Reddy, Vasudeva Reddy Minnam Gangneung Wonju Natl Univ, Dept Elect Engn, Kangnung 25457, South Korea; Yeungnam Univ, Sch Mech Engn, Gyongsan 38541, South Korea; Kyungpook Natl Univ, Sch Elect Engn, Daegu 41566, South Korea; Yeungnam Univ, Sch Chem Engn, Gyongsan 38541, South Korea VATTIKUTI, S/I-5237-2019 53064430100; 35300478500; 35096358900; 55422639100; 56524508600 ylkim@gwnu.ac.kr;dr.mspreddy@gmail.com;drmvasudr9@gmail.com; APPLIED PHYSICS A-MATERIALS SCIENCE & PROCESSING APPL PHYS A-MATER 0947-8396 1432-0630 127 8 SCIE MATERIALS SCIENCE, MULTIDISCIPLINARY;PHYSICS, APPLIED 2021 2.983 44.4 0.17 2025-07-30 4 3 Cadmium sulfide; Ferromagnetism; Optoelectronics; Spintronics; Photocatalysis OPTICAL-PROPERTIES; DYE DEGRADATION; QUANTUM DOTS; CO; FERROMAGNETISM; SPINTRONICS; MANGANESE; BLUE Cadmium sulfide; Ferromagnetism; Optoelectronics; Photocatalysis; Spintronics Cadmium sulfide; Energy gap; High resolution transmission electron microscopy; II-VI semiconductors; Nanocrystals; Nanomagnetics; Photocatalytic activity; Precipitation (chemical); Coprecipitation method; Doping concentration; Ion doping concentrations; Nanoparticle (NPs); Photocatalytic behaviors; Structural characterization; Superparamagnetics; Transmission electron microscopy images; CdS nanoparticles English 2021 2021-08 10.1007/s00339-021-04763-8 바로가기 바로가기 바로가기 바로가기
Article Tunable room temperature ferromagnetism and optical bandgap of CdS:Er nanoparticles A semiconductor compound, which portrays ferromagnetism with tunable optical and photoluminescence properties after a sensible doping of suitable dopant, is vital for modern spintronic and luminescent applications. In this sense, we fabricate CdS, Cd0.98Er0.02S, and Cd0.96Er0.04S nanoparticles (NPs) via an inexpensive co-precipitation way. No structural deformation was found in cubic CdS after Er (III) doping. The as-fabricated NPs demonstrated good crystallinity as well as slight changes in sizes varying 3 nm-7 nm. An X-ray photoelectron spectroscopy results confirmed that the impure-free nature of the prepared samples. A decreasing trend in the optical band gap was found by the increase in the doping level. The 1CdS NPs showed diamagnetic character, whereas the Er (III)-doped CdS NPs exhibited frail ferromagnetic character at room temperature, which slightly increased as a function of Er (III) concentration. Based on the literature, this is the initial magnetic report on the CdS:Er system and this will be very informative for the further magnetic investigations on the Er doping. Hence, the tunable optical and ferromagnetic magnetic properties of CdS:Er NPs demonstrated in this work may be beneficial for optoelectronic, solar cell and spintronic applications. Poornaprakash, B.; Mangiri, Ramanadha; Al-Kheraif, Abdulaziz A.; Divakar, Darshan Devang; Kim, Y. L.; Kumar, Mirgender; Reddy, M. Siva Pratap Yeungnam Univ, Dept Elect Engn, Gyongsan 38541, South Korea; Sri Venkateswara Univ, Dept Phys, Tirupati 517502, Andhra Pradesh, India; King Saud Univ, Coll Appl Med Sci, Dent Biomat Res Chair, Dent Hlth Dept, POB 10219, Riyadh 11433, Saudi Arabia; Kyungpook Natl Univ, Sch Elect Engn, Daegu 41566, South Korea Divakar, Darshan/G-4560-2016 53064430100; 57209315789; 6505582899; 56426619000; 35096358900; 56243663400; 55422639100 ylkim@gwnu.ac.kr;mkshekhawat22@gmail.com;dr.mspreddy@gmail.com; APPLIED PHYSICS A-MATERIALS SCIENCE & PROCESSING APPL PHYS A-MATER 0947-8396 1432-0630 127 5 SCIE MATERIALS SCIENCE, MULTIDISCIPLINARY;PHYSICS, APPLIED 2021 2.983 44.4 0.06 2025-07-30 2 1 CdS; Er; Optoelectronics; Spintronics CdS:Er; Optoelectronics; Spintronics Cadmium sulfide; CdS nanoparticles; Crystallinity; Energy gap; Ferromagnetic materials; Ferromagnetism; II-VI semiconductors; Optical band gaps; Precipitation (chemical); Semiconductor doping; X ray photoelectron spectroscopy; Doping levels; Ferromagnetic character; Nanoparticle (NPs); Photoluminescence properties; Room temperature ferromagnetism; Semiconductor compounds; Spintronic applications; Structural deformation; Erbium compounds English 2021 2021-05 10.1007/s00339-021-04508-7 바로가기 바로가기 바로가기 바로가기
Correction Tunable room temperature ferromagnetism and optical bandgap of CdS:Er nanoparticles (vol 127, 359, 2021) Poornaprakash, B.; Mangiri, Ramanadha; Al-Kheraif, Abdulaziz A.; Divakar, Darshan Devang; Kim, Y. L.; Kumar, Mirgender; Reddy, M. Siva Pratap Gangneung Wonju Natl Univ, Dept Elect Engn, Kangnung 25457, South Korea; Sri Venkateswara Univ, Dept Phys, Tirupati 517502, Andhra Pradesh, India; King Saud Univ, Coll Appl Med Sci, Dent Hlth Dept, Dent Biomat Res Chair, POB 10219, Riyadh 11433, Saudi Arabia; Yeungnam Univ, Dept Elect Engn, Gyongsan 38541, South Korea; Kyungpook Natl Univ, Sch Elect Engn, Daegu 41566, South Korea Divakar, Darshan/G-4560-2016 53064430100; 57209315789; 59743715000; 56426619000; 35096358900; 56243663400; 55422639100 ylkim@gwnu.ac.kr;mkshekhawat22@gmail.com;dr.mspreddy@gmail.com; APPLIED PHYSICS A-MATERIALS SCIENCE & PROCESSING APPL PHYS A-MATER 0947-8396 1432-0630 127 7 SCIE MATERIALS SCIENCE, MULTIDISCIPLINARY;PHYSICS, APPLIED 2021 2.983 44.4 0 2025-07-30 0 0 English 2021 2021-07 10.1007/s00339-021-04702-7 바로가기 바로가기 바로가기 바로가기
Article Robust controller design for systems with probabilistic uncertain parameters using multi-objective genetic programming Optimal design of controllers without considering uncertainty in the plant dynamics can induce feedback instabilities and lead to obtaining infeasible controllers in practice. This paper presents a multi-objective evolutionary algorithm integrated with Monte Carlo simulations (MCS) to perform the optimal stochastic design of robust controllers for uncertain time-delay systems. Each potential optimal solution represents a controller in the form of a transfer function with the optimal numerator and denominator polynomials. The proposed methodology uses genetic programming to evolve robust controllers. Using GP enables the algorithm to optimize the structure of the controller and tune the parameters in a holistic approach. The proposed methodology employs MCS to apply robust optimization and uses a new adaptive operator to balance exploration and exploitation in the search space. The performance of controllers is assessed in the closed-loop system with respect to three objective functions as (1) minimization of mean integral time absolute error (ITAE), (2) minimization of the standard deviation of ITAE and (3) minimization of maximum control effort. The new methodology is applied to the first-order and second-order systems with dead time. We evaluate the performance of obtained robust controllers with respect to the upper and lower bounds of step responses and control variables. We also perform a post-processing analysis considering load disturbance and external noise; we illustrate the robustness of the designed controllers by cumulative distribution functions of objective functions for different uncertainty levels. We show how the proposed methodology outperforms the state-of-the-art methods in the literature. Mallipeddi, Rammohan; Gholaminezhad, Iman; Saeedi, Mohammad S.; Assimi, Hirad; Jamali, Ali Kyungpook Natl Univ, Coll IT, Dept Artificial Intelligence, Daegu 41566, South Korea; Univ Guilan, Fac Mech Engn, Rasht, Iran; Univ Guilan, Dept Mech Engn, Univ Campus 2, Rasht, Iran; Univ Adelaide, Sch Comp Sci, Adelaide, SA 5005, Australia Saeedi, Mohammad/AFQ-1644-2022; Mallipeddi, Rammohan/AAL-5306-2020; Assimi, Hirad/O-8366-2018; Jamali, Ali/AAX-5841-2020; Assimi, Hirad/B-4931-2016 25639919900; 56216242400; 57217681683; 56513974300; 13805822900 mallipeddi.ram@gmail.com;ali.jamali@guilan.ac.ir; SOFT COMPUTING SOFT COMPUT 1432-7643 1433-7479 25 1 SCIE COMPUTER SCIENCE, ARTIFICIAL INTELLIGENCE;COMPUTER SCIENCE, INTERDISCIPLINARY APPLICATIONS 2021 3.732 44.5 0.24 2025-07-30 4 3 Genetic programming; Robust controller; Pareto; Monte Carlo simulation; Uncertainty DIFFERENTIAL EVOLUTION ALGORITHM; REACTIVE POWER DISPATCH; OPTIMIZATION Genetic programming; Monte Carlo simulation; Pareto; Robust controller; Uncertainty Closed loop systems; Delay control systems; Distribution functions; Genetic algorithms; Genetic programming; Intelligent systems; Monte Carlo methods; Optimal systems; Polynomials; Robust control; Stochastic systems; Uncertainty analysis; Cumulative distribution function; Denominator polynomials; Integral time absolute errors; Multi objective evolutionary algorithms; Robust controller design; State-of-the-art methods; Uncertain time-delay system; Upper and lower bounds; Controllers English 2021 2021-01 10.1007/s00500-020-05133-x 바로가기 바로가기 바로가기 바로가기
Article Safety and efficacy of everolimus (EVE) plus exemestane (EXE) in postmenopausal women with locally advanced or metastatic breast cancer: final results from EVEREXES Background This study was conducted to collect clinical safety, tolerability, and efficacy data with the use of everolimus (EVE) combined with exemestane (EXE) in patients with advanced breast cancer (ABC). Methods The EVEREXES trial initiated in 2012, provided early access to the first dual blockade treatment with EVE + EXE in patients with HR+, HER2 - ABC in Asia and other emerging growth countries. Postmenopausal women with HR+, HER2 - ABC who had documented recurrence or progression, following a nonsteroidal aromatase inhibitor therapy, were treated with EVE (10 mg/day) + EXE (25 mg/day) orally. Results A total of 235 patients received >= 1 dose of study medication. At the end of the study, all patients ceased the treatment. Disease progression (66.0%) was the primary reason of discontinuation. The most common AEs (>= 20%) were stomatitis, decreased appetite, hyperglycemia, rash, aspartate aminotransferase increased, anemia, alanine aminotransferase increased, cough, and fatigue. No new safety concerns were identified in the current study. Median progression-free survival (PFS) in the Asian subset was similar to that of the overall population (9.3 months in both groups). Confirmed overall response rate (ORR) was achieved for 19.6% of the patients. Efficacy of EVE + EXE across subgroups (prior CT, line of treatment, and presence of visceral metastases) was maintained. Conclusion The safety and efficacy results from EVEREXES trial are consistent to data previously reported in BOLERO-2. These results support that EVE + EXE could be a viable treatment option for the postmenopausal women with HR+, HER2 - ABC in Asian region. Im, Young-Hyuck; Karabulut, Bulent; Lee, Keun Seok; Park, Byeong-Woo; Adhav, Aditya; Cinkir, Havva Yesil; Abdel-Razeq, Hikmat; Chang, Yuan-Ching; Aksoy, Sercan; Im, Seock-Ah; Jeong, Joon; Chae, Yeesoo; Bowles, James; Slimane, Khemaies; Xue, Hongling; Kim, Sung-Bae Sungkyunkwan Univ, Div Hematol Oncol, Dept Med, Samsung Med Ctr,Sch Med, Seoul, South Korea; Ege Univ, Dept Med Oncol, Fac Med, Izmir, Turkey; Natl Canc Ctr, Ctr Breast Canc, Gyeonggi Do, South Korea; Yonsei Univ Hlth Syst, Dept Surg, Severance Hosp, Seoul, South Korea; HCG Manavata Canc Ctr, Dept Surg Oncol, Nasik, India; Gaziantep Univ, Dept Med Oncol, Med Fac, Gaziantep, Turkey; King Hussein Canc Ctr, Amman, Jordan; Mackay Mem Hosp, Taipei, Taiwan; Hacettepe Univ, Med Fac, Ankara, Turkey; Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul Natl Univ Hosp, Seoul, South Korea; Yonsei Univ Hlth Syst, Gangnam Severance Hosp, Dept Surg, Seoul, South Korea; Kyungpook Natl Univ Hosp, Daegu, South Korea; Novartis Pharma AG, Basel, Switzerland; Novartis Asia Pacific Pharmaceut Pte Ltd, Singapore, Singapore; Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South Korea Kim, Sung-Bae/JXL-8219-2024; Im, Seock-Ah/J-5620-2012; Aksoy, Sercan/S-2480-2019; Park, Joonhong/AAZ-9885-2020 7103344010; 6603897212; 17137276100; 7402834528; 57207776183; 55925639100; 6602398256; 7501844206; 7006512389; 34570185300; 55184774900; 57190793908; 57222495559; 6603436777; 57222488823; 34770722200 imyh00@skku.edu; BREAST CANCER RESEARCH AND TREATMENT BREAST CANCER RES TR 0167-6806 1573-7217 188 1 SCIE ONCOLOGY 2021 4.624 44.7 0.83 2025-07-30 12 14 EVEREXES; Breast Cancer; Everolimus; Exemestane; HR  +  HER2  −   Mammalian target of rapamycin (mTOR) Breast Cancer; EVEREXES; Everolimus; Exemestane; HER2 −; HR +; Mammalian target of rapamycin (mTOR) Androstadienes; Antineoplastic Combined Chemotherapy Protocols; Asia; Breast Neoplasms; Everolimus; Female; Humans; Neoplasm Recurrence, Local; Postmenopause; Receptor, ErbB-2; Sirolimus; everolimus; exemestane; mammalian target of rapamycin; androstane derivative; antineoplastic agent; epidermal growth factor receptor 2; everolimus; exemestane; rapamycin; adult; advanced cancer; alanine aminotransferase blood level; anemia; aphthous stomatitis; arthralgia; Article; Asia; Asian; aspartate aminotransferase blood level; asthenia; backache; cancer growth; cancer recurrence; coughing; decreased appetite; diarrhea; drug efficacy; drug safety; drug tolerability; dry skin; dysgeusia; dyslipidemia; dyspepsia; dyspnea; endocrine disease; epistaxis; eye disease; fatigue; female; fever; headache; human; hypercholesterolemia; hyperglycemia; hyperlipidemia; hypertriglyceridemia; hypokalemia; hypophosphatemia; insomnia; major clinical study; metastatic breast cancer; middle aged; mouth ulcer; multicenter study; myalgia; nail disease; nausea; open study; peripheral edema; phase 3 clinical trial; pneumonia; postmenopause; productive cough; progression free survival; pruritus; rash; side effect; stomatitis; thrombocytopenia; upper respiratory tract infection; vomiting; breast tumor; postmenopause; tumor recurrence English 2021 2021-07 10.1007/s10549-021-06173-z 바로가기 바로가기 바로가기 바로가기
Article Severe Cutaneous Adverse Reactions to Anti-tuberculosis Drugs in Korean Patients Purpose: Anti-tuberculosis drugs (ATDs) can cause severe cutaneous adverse reactions (SCARs) such as Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and drug reaction with eosinophilia and systemic symptoms (DRESS). Underlying tuberculous infection and co-administration of multiple drugs may contribute to the complexity of ATD-related SCARs. This study aimed to investigate the clinical characteristics and outcomes of ATD-related SCARs. Methods: We analyzed ATD-related SCAR cases in 2010-2015, selected from a web-based Database of the Korean Registry of SCAR. Results: Among 783, 53 patients with ATD-induced SCARs were enrolled, including 12 with SJS/TEN (22.6%) and 41 with DRESS (77.4%). When comparing the ATD and non-ATD groups, the prevalence of DRESS patients was higher in the ATD group than in the non-ATD group (77.4% vs. 45.8%, P< 0.001). Among patients with ATD-related SCARs, those with SJS/TEN were significantly older, had higher intensive care unit admissions, and had higher mortality than those with DRESS (70.5 vs. 50.0 years, P< 0.001; 41.7% vs. 6.1%, P= 0.010; and 33.3% vs. 2.5%, P= 0.003, respectively). ATDs were challenged in 14 cases. The ATD associated most often with SCAR cases was rifampin (81.8%), followed by isoniazid (66.7%), ethambutol (50.0%), pyrazinamide (33.3%). Six patients (42.9%) had hypersensitivity reactions to 2 or more drugs. Conclusions: DRESS was more common among the ATD-related SCAR cases. Although treatment with most ATDs carries the risk of SCAR development, the use of rifampin was most frequently involved in the occurrence of SCARs. Multiple hypersensitivity was frequently observed in ATD-related SCARs. Jin, Hyun Jung; Kang, Dong Yoon; Nam, Young Hee; Ye, Young Min; Koh, Young-Il; Hur, Gyu-Young; Kim, Sae-Hoon; Yang, Min-Suk; Kim, Sujeong; Jeong, Yi Yeong; Kim, Min-Hye; Choi, Jeong Hee; Kang, Hye-Ryun; Jo, Eun-Jung; Park, Hye-Kyung Yeungnam Univ, Dept Internal Med, Med Sch, Daegu, South Korea; Seoul Natl Univ Hosp, Drug Safety Monitoring Ctr, Seoul, South Korea; Dong A Univ, Dept Internal Med, Coll Med, Busan, South Korea; Ajou Univ, Dept Allergy & Clin Immunol, Sch Med, Suwon, South Korea; Chonnam Natl Univ Hosp, Dept Internal Med, Gwangju, South Korea; Korea Univ, Dept Internal Med, Coll Med, Seoul, South Korea; Seoul Natl Univ, Dept Internal Med, Bundang Hosp, Seongnam, South Korea; SMG SNU Boramae Med Ctr, Dept Internal Med, Seoul, South Korea; Kyungpook Natl Univ, Sch Med, Dept Internal Med, Daegu, South Korea; Gyeongsang Natl Univ, Gyeongsang Natl Univ Hosp, Dept Internal Med, Coll Med, Jinju, South Korea; Ewha Womans Univ, Coll Med, Dept Internal Med, Seoul, South Korea; Hallym Univ, Dongtan Sacred Heart Hosp, Hwaseong & Allergy & Clin Immunol Res Ctr, Dept Pulmonol & Allergy,Coll Med, Chunchon, South Korea; Seoul Natl Univ, Dept Internal Med, Coll Med, Seoul, South Korea; Pusan Natl Univ, Dept Internal Med, Coll Med, 179 Gudeok Ro, Busan 49241, South Korea ; Kim, Ju-Hyoung/N-1450-2019; Yang, Min-Suk/GVT-0863-2022; Park, Hye-Kyung/Q-5586-2019; Kim, Sae/AAR-3907-2020; Jin, Hyunjung/MHR-8031-2025 36157127500; 37077171700; 37006947800; 13405438300; 58914386100; 7004193730; 35198322400; 7404927140; 36666447400; 7202332057; 58045929900; 7501395695; 7404070922; 55572136700; 57208252986 parkhk@pusan.ac.kr; ALLERGY ASTHMA & IMMUNOLOGY RESEARCH ALLERGY ASTHMA IMMUN 2092-7355 2092-7363 13 2 SCIE ALLERGY;IMMUNOLOGY 2021 5.096 44.8 1.29 2025-07-30 23 21 Antitubercular agents; severe cutaneous adverse reactions; Stevens-Johnson syndrome; toxic epidermal necrolysis; drug reaction with eosinophilia and systemic symptoms; drug hypersensitivity syndrome; skin; isoniazid; rifampin TOXIC EPIDERMAL NECROLYSIS; STEVENS-JOHNSON SYNDROME; INDUCED HYPERSENSITIVITY; ETHAMBUTOL; DIAGNOSIS Antitubercular agents; Drug hypersensitivity syndrome; Drug reaction with eosinophilia and systemic symptoms; Isoniazid; Rifampin; Severe cutaneous adverse reactions; Skin; Stevens-Johnson syndrome; Toxic epidermal necrolysis English 2021 2021-03 10.4168/aair.2021.13.2.245 바로가기 바로가기 바로가기 바로가기
Editorial Material Sex and Treatable Traits in Severe Asthma Park, Han-Ki; Song, Woo-Jung Kyungpook Natl Univ, Sch Med, Chilgok Hosp, Dept Allergy & Clin Immunol, Daegu, South Korea; Univ Ulsan, Coll Med, Asan Med Ctr, Dept Allergy & Clin Immunol, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea Park, Han-Ki/AAY-3102-2020 57218664064; 37062104600 swj0126@amc.seoul.kr; ALLERGY ASTHMA & IMMUNOLOGY RESEARCH ALLERGY ASTHMA IMMUN 2092-7355 2092-7363 13 2 SCIE ALLERGY;IMMUNOLOGY 2021 5.096 44.8 0.08 2025-07-30 2 2 PREVALENCE antiasthmatic agent; immunoglobulin; immunoglobulin E; airway obstruction; asthma; body mass; comorbidity; coughing; disease severity; dyspnea; eosinophil; eosinophilia; female; fractional exhaled nitric oxide; functional neuroimaging; gastroesophageal reflux; human; human cell; immunoglobulin blood level; inflammation; Italy; lung function; major clinical study; male; morbid obesity; multicenter study; nose polyp; phenotype; respiratory tract inflammation; Review; sensitization; sensory neuropathy; sex difference; smoking; symptomatology English 2021 2021-03 10.4168/aair.2021.13.2.167 바로가기 바로가기 바로가기 바로가기
Article Assessment of the effect on soil microbial communities of genetically modified soybean and a hybrid from crossing with wild soybean Microbial community analysis of the rhizosphere is one of many approaches for evaluating the environmental impact of genetically modified (GM) crops. To elucidate the influence of GM and hybrid soybeans on the bacterial community of the rhizosphere, this study used a beta-carotene-enhanced transgenic soybean as the GM crop, modified from Kwangan soybean (Glycine max (L.) Merrill), and a hybrid soybean line in which this GM soybean line had been crossed with wild soybean (Glycine soja). Bacterial community analysis indicated that compared to their non-transgenic counterpart, there were no significant effects on the rhizospheres of either the GM or hybrid soybeans. The bacterial densities of the rhizosphere of hybrid and GM soybeans were found to be within the range of those of non-GM soybeans. We found no horizontal gene transfer from GM and hybrid soybeans to soil rhizosphere microorganisms by PCR analysis. Therefore, our results suggest that the impact of GM and hybrid soybeans on the environment, especially on soil microorganisms, is insignificant. Oh, Sung-Dug; Jang, Ye-Jin; Park, Soo-Yun; Lee, Kijong; Lee, Seong-Kon; Yun, Doh-Won; Suh, Sang Jae; Chae, Jong-Chan Rural Dev Adm, Natl Inst Agr Sci, Dept Agr Biotechnol, Jeonju 54874, South Korea; Kyungpook Natl Univ, Sch Appl Biosci, Daegu 41566, South Korea; Jeonbuk Natl Univ, Div Biotechnol, Iksan 54596, South Korea; Jeonbuk Natl Univ, Adv Inst Environm & Biosci, Iksan 54596, South Korea ; Lee, Seong/B-7412-2012 7404104129; 55612018200; 45661697500; 57219704626; 37056895800; 7103133449; 15754843200; 7102478062 chae@jbnu.ac.kr; PLANT BIOTECHNOLOGY REPORTS PLANT BIOTECHNOL REP 1863-5466 1863-5474 15 6 SCIE BIOTECHNOLOGY & APPLIED MICROBIOLOGY;PLANT SCIENCES 2021 2.496 45.0 0.66 2025-07-30 7 8 Microbial community; GM soybean; Hybrid soybean; Safety of GM crops; Horizontal gene transfer GLYCINE-MAX L.; GENE-TRANSFER; IDENTIFICATION; TRANSFORMATION; RISKS; DNA GM soybean; Horizontal gene transfer; Hybrid soybean; Microbial community; Safety of GM crops English 2021 2021-12 10.1007/s11816-021-00710-4 바로가기 바로가기 바로가기 바로가기
Article Importance of Serum Ferritin Level for Early Diagnosis and Differentiation in Patients with Kawasaki Disease with Macrophage Activation Syndrome We aimed to evaluate the utility of the serum ferritin level as an early screening test of Kawasaki disease with macrophage activation syndrome (KD-MAS). We analyzed the serum ferritin levels on the first day of admission and the clinical progress of patients diagnosed with complete or incomplete KD. Of the 158 patients, 5 were diagnosed with KD-MAS. Conjunctival injection was significantly more frequent in KD group (p = 0.035), although there were no significant differences in other clinical features. On the first day of admission, the serum ferritin level in the KD-MAS group was >500 ng/mL, which was higher than that in the KD group (p = 0.001). In the KD-MAS group, total bilirubin, triglyceride, and lactate dehydrogenase (LDH) were significantly higher, and erythrocyte sedimentation rate (ESR), total protein, albumin, and fibrinogen were significantly lower than the KD group (p < 0.05). Four patients were diagnosed with MAS within 7 days after admission, and 4 (80%) patients with KD-MAS survived. In conclusion, carrying out an early ferritin screening test is important in patients with principal clinical features that may suspect KD. We propose to include ferritin level in the primary laboratory test to differentiate between KD with and without MAS early. Roh, Da Eun; Kwon, Jung Eun; Choi, Hee Joung; Kim, Yeo Hyang Kyungpook Natl Univ, Sch Med, Dept Pediat, Daegu 41405, South Korea; Kyungpook Natl Univ, Childrens Hosp, Div Pediat Cardiol, Daegu 41404, South Korea; Keimyung Univ, Sch Med, Dongsan Hosp, Dept Pediat, Daegu 42601, South Korea 57195734230; 57194002366; 25937150300; 57032023800 ponyks1004@naver.com;lovecello623@gmail.com;joung-756@hanmail.net;kimyhmd@knu.ac.kr; CHILDREN-BASEL CHILDREN-BASEL 2227-9067 8 4 SCIE PEDIATRICS 2021 2.835 45.0 1.24 2025-07-30 9 10 ferritin; fever; kawasaki disease; macrophage activation syndrome Ferritin; Fever; Kawasaki disease; Macrophage activation syndrome alanine aminotransferase; albumin; amino terminal pro brain natriuretic peptide; aspartate aminotransferase; bilirubin; C reactive protein; ferritin; fibrinogen; lactate dehydrogenase; triacylglycerol; adolescent; adult; alanine aminotransferase blood level; albumin blood level; Article; aspartate aminotransferase blood level; bilirubin blood level; clinical feature; controlled study; differential diagnosis; early diagnosis; echocardiography; erythrocyte sedimentation rate; female; ferritin blood level; fibrinogen blood level; hemoglobin blood level; hospital admission; human; human cell; laboratory test; lactate dehydrogenase blood level; leukocyte count; macrophage activation syndrome; major clinical study; male; mucocutaneous lymph node syndrome; neutrophil percentage; platelet count; prospective study; protein analysis; triacylglycerol blood level; university hospital English 2021 2021-04 10.3390/children8040269 바로가기 바로가기 바로가기 바로가기
Article Longitudinal Changes in Serum Creatinine Levels and Urinary Biomarkers in Late Preterm Infants during the First Postnatal Week: Association with Acute Kidney Injury and Treatment with Aminoglycoside We aimed to determine the incidence of acute kidney injury (AKI) and longitudinal changes in SCr levels and urinary biomarkers associated with AKI and aminoglycoside (AG) medication during the first week of life of late preterm infants. Urine biomarkers and SCr were measured in thirty late preterm infants on days one, two, five, and seven postnatal. Urine biomarkers included neutrophil gelatinase-associated lipocalin (NGAL), monocyte chemotactic protein-1 (MCP-1), epidermal growth factor (EGF), Tamm-Horsfall glycoprotein (THP), and liver fatty-acid-binding protein (L-FABP). Gestational age was positively correlated with SCr levels at birth, but inversely correlated with SCr levels at day five and day seven. Eighteen (60%) infants had stage 1 AKI, and twenty (67%) infants were treated with AGs. Infants with AKI had lower gestational age and lower birth weight than those without AKI. Urinary biomarkers adjusted according to uCr levels in infants with AKI were not statistically different from those in infants without AKI. There were no significant differences in incidence of AKI, and SCr levels during and after cessation of AG treatment. The uMCP-1/Cr ratio at days five and seven was higher in infants treated with AG than in non-treated infants. Lee, Sang-Yoon; Moon, Jung-Eun; Park, Sook-Hyun Kyunpook Natl Univ, Sch Med, Dept Pediat, Daegu 41404, South Korea; Kyungpook Natl Univ, Chilgok Hosp, Dept Pediat, Daegu 41404, South Korea 57224403293; 57205770947; 57194595004 gguggusy@gmail.com;subuya@hanmail.net;park_sh@knu.ac.kr; CHILDREN-BASEL CHILDREN-BASEL 2227-9067 8 10 SCIE PEDIATRICS 2021 2.835 45.0 0.31 2025-07-30 2 2 acute kidney injury; aminoglycoside; urinary biomarkers; serum creatinine GELATINASE-ASSOCIATED LIPOCALIN; EPIDERMAL-GROWTH-FACTOR; ACUTE-RENAL-FAILURE; GESTATIONAL-AGE; MATURATION; HEALTH; SEX Acute kidney injury; Aminoglycoside; Serum creatinine; Urinary biomarkers aminoglycoside; ampicillin; biological marker; creatinine; epidermal growth factor; fatty acid binding protein; gentamicin; monocyte chemotactic protein 1; neutrophil gelatinase associated lipocalin; Tamm Horsfall glycoprotein; acute kidney failure; antibiotic therapy; Article; birth weight; body weight loss; clinical article; clinical assessment; controlled study; correlation analysis; creatinine blood level; disease classification; female; gestational age; human; incidence; infant; longitudinal study; male; outcome assessment; perinatal period; pneumonia; prematurity; sepsis; treatment response; urinalysis English 2021 2021-10 10.3390/children8100896 바로가기 바로가기 바로가기 바로가기
Article Treatment Outcomes of Pediatric Acute Myeloid Leukemia in the Yeungnam Region: A Multicenter Retrospective Study of the Study Alliance of Yeungnam Pediatric Hematology-Oncology (SAYPH) Acute myeloid leukemia (AML) is the second most common pediatric leukemia, with a survival rate of 70%. In this retrospective study, we evaluated the treatment outcomes of pediatric AML among 144 patients diagnosed between 2000 and 2013. After induction, 80.6% of patients achieved complete remission (CR). The 5-year overall survival (OS) and event-free survival (EFS) rates were 58.8 +/- 4.2% and 49.8 +/- 4.2%, respectively. Based on the response to induction therapy, the 5-year OS was 66.9 +/- 5.7% in patients with CR (p < 0.001). Ninety-nine patients with CR after induction therapy were examined, and their 5-year OS and EFS were 66.4 +/- 4.9% and 56.3 +/- 5.1%, respectively. The 5-year OS rates according to treatment were 59.9 +/- 7.4% in the chemotherapy group and 72.3 +/- 6.3% in the hematopoietic stem cell transplantation (HSCT) group (p = 0.089). The EFS was 50.1 +/- 7.4% in the chemotherapy group and 61.7 +/- 6.9% in the HSCT group (p = 0.098). OS and EFS according to cytogenetics were insignificant. Our findings confirmed that the response to induction treatment was important for survival and HSCT had no significant survival benefits compared with those of chemotherapy. Moreover, many early induction deaths under the age of 2 years were observed. Lee, Jae Min; Yang, Eu Jeen; Park, Kyung Mi; Lee, Young-Ho; Chueh, Heewon; Hah, Jeong Ok; Park, Ji Kyoung; Lim, Jae Young; Park, Eun Sil; Park, Sang Kyu; Kim, Heung Sik; Shim, Ye Jee; Park, Jeong A.; Choi, Eun Jin; Lee, Kun Soo; Kim, Ji Yoon; Lim, Young Tak Yeungnam Univ, Dept Pediat, Coll Med, Daegu 42415, South Korea; Pusan Natl Univ, Dept Pediat, Childrens Hosp, Sch Med, Yangsan 50612, South Korea; Hanyang Univ, Coll Med, Dept Pediat, Med Ctr, Seoul 04763, South Korea; Dong A Univ, Coll Med, Dept Pediat, Busan 49201, South Korea; Daegu Fatima Hosp, Dept Pediat, Daegu 41199, South Korea; Inje Univ, Coll Med, Busan Paik Hosp, Dept Pediat, Busan 47392, South Korea; Gyeongsang Natl Univ, Coll Med, Dept Pediat, Jinju 52727, South Korea; Ulsan Univ Hosp, Dept Pediat, Ulsan 44033, South Korea; Keimyung Univ, Sch Med, Daegu Dongsan Hosp, Dept Pediat, Daegu 41931, South Korea; Keimyung Univ, Dongsan Hosp, Dept Pediat, Sch Med, Daegu 42601, South Korea; Inje Univ, Haeundae Paik Hosp, Dept Pediat, Busan 41808, South Korea; Mem Sloan Kettering Canc Ctr, Dept Pediat, Manhattan, KS 10065 USA; Daegu Catholic Univ, Dept Pediat, Med Ctr, Daegu 42472, South Korea; Kyungpook Natl Univ, Sch Med, Dept Pediat, Daegu 41944, South Korea Lee, Jae Min/H-8475-2013; Lee, Jaewoong/IQS-0514-2023; Lee, Kyung-Yil/AFR-4174-2022; Park, Jung Hoon/CZZ-0090-2022 39261799700; 56594276100; 57196342718; 43262250600; 39261421100; 7003942219; 35332704400; 55555512300; 26030635800; 57209835309; 7410134477; 57222517942; 36141994300; 35075812900; 7501501684; 57205408095; 7402565128 mopic@yu.ac.kr;41sirius@hanmail.net;mayani@hanmail.net;cord@hanyang.ac.kr;caaf80@empal.com;johah@med.yu.ac.kr;pjk4285@hanmail.net;pedneu@gnu.ac.kr;espark@gnu.ac.kr;sangulsan@hanmail.net;kimhs@dsmc.or.kr;yejeeshim@dsmc.or.kr;jeonga95@gmail.com;ejchoi2@cu.ac.kr;kslee@knu.ac.kr;phojyk@gmail.com;limyt@pusan.ac.kr; CHILDREN-BASEL CHILDREN-BASEL 2227-9067 8 2 SCIE PEDIATRICS 2021 2.835 45.0 0.62 2025-07-30 4 4 acute myeloid leukemia; hematopoietic stem cell transplantation; prognosis; pediatric; childhood; Korea CELL TRANSPLANTATION; CHILDREN; SARCOMA; CANCER; TRIAL Acute myeloid leukemia; Childhood; Hematopoietic stem cell transplantation; Korea; Pediatric; Prognosis antineoplastic agent; acute myeloid leukemia; Article; cancer mortality; cancer patient; cancer prognosis; cancer survival; child; childhood; clinical outcome; controlled study; cytogenetics; drug response; event free survival; female; hematology; hematopoietic stem cell transplantation; human; human cell; induction chemotherapy; leukemia remission; major clinical study; male; oncology; outcome assessment; overall survival; pediatric patient; preschool child; retrospective study; school child; South Korea; study design; survival rate English 2021 2021-02 10.3390/children8020109 바로가기 바로가기 바로가기 바로가기
Article Carbamazepine biodegradation and volatile fatty acids production by selectively enriched sulfate-reducing bacteria and fermentative acidogenic bacteria BACKGROUND The micropollutant carbamazepine (CBZ) is persistent and resistant to conventional wastewater treatment. This study investigated the role of fermentative acidogenic bacteria (FAB) and sulfate-reducing bacteria (SRB) for CBZ biodegradation and volatile fatty acid (VFA) production. RESULTS The experimental results demonstrated that CBZ biodegradation, total organic carbon and sulfate removal efficiency reached 46%, 36% and 98%, respectively, after 144 h of operation with VFA production of acetic acid (20.72 mmol L-1), propionic acid (3.67 mmol L-1) and butyric acid (4.90 mmol L-1). However, the acetate fraction decreased from 78% to 70% with a decrease in chemical oxygen demand/sulfate (COD:SO42-) ratios from 1.06 to 0.35, respectively, suggesting that acetate was partially oxidized by SRB under substrate/COD limiting conditions. The biodegradation performance of SRB + FAB was also compared with that of a mixed microbial community (MMC). CONCLUSIONS Upon increasing the initial CBZ concentration from 42.3 to 169.2 mu mol L-1, SRB + FAB exhibited much higher CBZ biodegradation (33%) than MMC (12%). Microbial community analyses confirmed the enrichment of VFA-producing species including phylum Firmicutes (2.4% to 36.8%) and class Clostridia (1.3% to 29.6%). Moreover, aromatic and nitroaromatic compound-degrading bacteria such asEscherichiaandDesulfovibriowere also enriched. This signifies the applicability of SRB + FAB to pharmaceutical pollutant biodegradation in the environment. (c) 2020 Society of Chemical Industry (SCI) Tahir, Khurram; Miran, Waheed; Jang, Jiseon; Shahzad, Asif; Moztahida, Mokrema; Kim, Bolam; Lim, Seong-Rin; Lee, Dae Sung Kyungpook Natl Univ, Dept Environm Engn, 80 Daehak Ro, Daegu 41566, South Korea; COMSATS Univ Islamabad, Dept Chem Engn, Lahore, Pakistan; Natl Inst Mat Sci, Int Ctr Mat Nanoarchitecton, Ibaraki, Japan; Korea Radioact Waste Agcy, R&D Inst Radioact Wastes, Daejeon, South Korea; Kangwon Natl Univ, Dept Environm Engn, Chunchon 24341, Gangwon, South Korea Miran, Waheed/G-6671-2016; Tahir, Khurram/KFS-5321-2024 57207114377; 57195984440; 56611137400; 57190382338; 57202904382; 57208922438; 14626162700; 55568524907 srlim@kangwon.ac.kr;daesung@knu.ac.kr; JOURNAL OF CHEMICAL TECHNOLOGY AND BIOTECHNOLOGY J CHEM TECHNOL BIOT 0268-2575 1097-4660 96 3 SCIE BIOTECHNOLOGY & APPLIED MICROBIOLOGY;CHEMISTRY, MULTIDISCIPLINARY;ENGINEERING, CHEMICAL;ENGINEERING, ENVIRONMENTAL 2021 3.709 45.1 0.52 2025-07-30 9 9 carbamazepine; biodegradation; sulfate-reducing bacteria; fermentative acidogenic bacteria INFLUENT COD/SO42-RATIOS; WASTE-WATER; PHARMACEUTICAL COMPOUNDS; ANAEROBIC BIODEGRADATION; BIOLOGICAL TREATMENT; ACTIVATED-SLUDGE; DEGRADATION; REMOVAL; DICLOFENAC; BIOTRANSFORMATION biodegradation; carbamazepine; fermentative acidogenic bacteria; sulfate-reducing bacteria Amides; Aromatic compounds; Bacteria; Biodegradation; Butyric acid; Chemical industry; Chemical oxygen demand; Organic carbon; Propionic acid; Sulfur compounds; Wastewater treatment; acetic acid; aromatic nitro compound; butyric acid; carbamazepine; propionic acid; sulfate; Acidogenic bacterium; Biodegradation performance; Limiting condition; Microbial communities; Microbial community analysis; Nitroaromatic compound; Sulfate reducing bacteria; Total Organic Carbon; abiotic stress; Article; bacterium; chemical oxygen demand; Clostridia; concentration (parameter); controlled study; Desulfovibrio; Escherichia; fermentative acidogenic bacterium; Firmicutes; microbial community; microbial degradation; nonhuman; organisms by metabolism; phylum; pollutant; reactor operation; sulfate reducing bacterium; total organic carbon; Volatile fatty acids English 2021 2021-03 10.1002/jctb.6572 바로가기 바로가기 바로가기 바로가기
Article Identification of suberosin metabolites in human liver microsomes by high-performance liquid chromatography combined with high-resolution quadrupole-orbitrap mass spectrometer Suberosin is a natural prenylated coumarin derivative isolated fromCitropsis articulata.It has various pharmacological properties, especially as an anticoagulant, for which it has been used since antiquity. However, its metabolic pathway and metabolites have not yet been studied. Therefore, this study characterizes its metabolic pathway and metabolites in human liver microsomes (HLMs) using high-resolution quadrupole-orbitrap mass spectrometry (HRMS/MS). Eight metabolites (M1-M8) were found, including three monohydroxylated (M1-M3), one hydrated (M4), three dihydroxylated (M5-M7), and one glucuronide conjugate (M8). Furthermore, forms of cytochrome P450 (CYPs) responsible for suberosin metabolism in HLMs were characterized. CYP1A2 was identified as a major enzyme for the production of M1 and M5 metabolites. The M2, M3, and M7 metabolites were predominantly generated by CYP2B6. M8 was the only phase II metabolite, identified as a glucuronide conjugate from either M1 or M2. This glucuronide conjugate may be the only promising metabolite from phase II metabolism. Phase I metabolism, especially hydroxylation, was found to provide a predominant metabolic pathway of suberosin in HLMs. Further studies should be conducted to explore the metabolites, examining their efficacy and their toxicity in an in vivo system. Paudel, Sanjita; Kim, Younah; Choi, Su Min; Kim, Ju-Hyun; Bae, Jong-Sup; Lee, Taeho; Lee, Sangkyu Kyungpook Natl Univ, Pharmaceut Sci Res Inst, Coll Pharm, BK21 Plus KNU Multiomics Based Creat Drug Res Tea, Daegu 41566, South Korea; Yeungnam Univ, Coll Pharm, Gyongsan 38541, South Korea Bae, Jong-Sup/AAU-9724-2020 57203320448; 57211893872; 57212768203; 55720031300; 16021543200; 57204032003; 57209046767 tlee@knu.ac.kr;sangkyu@knu.ac.kr; JOURNAL OF MASS SPECTROMETRY J MASS SPECTROM 1076-5174 1096-9888 56 4 SCIE BIOCHEMICAL RESEARCH METHODS;CHEMISTRY, ANALYTICAL;SPECTROSCOPY 2021 2.394 45.4 0.17 2025-07-30 2 2 cytochrome P450; human liver microsomes; hydroxylation; metabolic pathway; suberosin metabolism HUMAN CYTOCHROME-P450 2A6; COUMARIN; ISOXANTHOHUMOL; PRODUCTS cytochrome P450; human liver microsomes; hydroxylation; metabolic pathway; suberosin metabolism Chromatography, High Pressure Liquid; Coumarins; Cytochrome P-450 CYP1A2; Cytochrome P-450 Enzyme System; Humans; Hydroxylation; Isomerism; Metabolic Networks and Pathways; Metabolome; Microsomes, Liver; Molecular Conformation; Oxidation-Reduction; Tandem Mass Spectrometry; Biomolecules; Drug products; High performance liquid chromatography; Mass spectrometry; Metabolism; coumarin derivative; cytochrome P450 1A1; cytochrome P450 1A2; cytochrome P450 2A6; cytochrome P450 2B6; cytochrome P450 3A4; cytochrome P450 3A5; drug metabolite; suberosin; unclassified drug; coumarin derivative; CYP1A2 protein, human; cytochrome P450; cytochrome P450 1A2; suberosin; Coumarin derivatives; Cytochrome p450; Glucuronide conjugates; High resolution; Human liver microsomes; Metabolic pathways; Orbitrap mass spectrometries; Pharmacological properties; Article; controlled study; dihydroxylation; drug efficacy; drug hydroxylation; drug identification; drug metabolism; drug structure; electrospray; high resolution quadrupole orbitrap mass spectrometry; human; human tissue; hydration; hydroxylation; in vitro study; in vivo study; liver metabolism; liver microsome; mass spectrometry; phenotype; priority journal; protein expression; retention time; reversed phase liquid chromatography; sulfation; tandem mass spectrometry; ultra performance liquid chromatography; chemistry; conformation; high performance liquid chromatography; isomerism; liver microsome; metabolism; metabolome; oxidation reduction reaction; physiology; Metabolites English 2021 2021-04 10.1002/jms.4623 바로가기 바로가기 바로가기 바로가기
Article Mechanism behind the paper spray chemical ionization phenomenon and the choice of solvent Paper spray chemical ionization (PSCI) combined with mass spectrometry has been proposed as a sensitive method for the analysis of nonpolar aromatic compounds; however, the mechanism behind PSCI is not well understood. In the present study, the evidence for the occurrence of corona discharge is provided and its mechanism is proposed. Photographs taken with a highly sensitive camera evidently demonstrate the occurrence of corona discharge at the end of the triangular shape tip when a nonpolar solvent such as hexane was used at an applied potential of 6-7 kV. Nevertheless, corona discharge was not observed in the presence of a polar solvent. The occurrence of the corona discharge was attributed to charge accumulation in the dielectric layer generated by the nonpolar solvent on the fibers of the paper tip. Specifically, corona discharge was generated at the tip end when the charge approached a critical threshold. In the presence of a polar solvent, however, the dielectric layer was not generated and, hence, corona discharge was not observed. Based on this information, three nonpolar solvents were selected and their sensitivity for analyzing the phenanthrene and maltene fractions of crude oil was evaluated. Chlorobenzene provided the highest signal abundance; therefore, it was suggested as the optimum solvent for PSCI. Notably, the fundamental understanding of corona discharge in PSCI acquired in this study provides a basis for further improvement of this technique by way of surface modification. Kim, Hyungjun; Lee, Hyunwoo; Kum, Daesub; Tae, Heungsik; Cha, Sangwon; Kim, Donghwi; Kim, Sunghwan Kyungpook Natl Univ, Dept Chem, Daegu 41566, South Korea; Kyungpook Natl Univ, Coll IT Engn, Sch Elect Engn, Daegu 41566, South Korea; Dongguk Univ, Dept Chem, Seoul 04620, South Korea; Korea Inst Ocean Sci & Technol, Risk Assessment Res Ctr, Geoje 53201, South Korea; Kyungpook Natl Univ, Mass Spectrometry Convergence Res Ctr, Daegu 41566, South Korea; Kyungpook Natl Univ, Green Nano Mat Res Ctr, Daegu 41566, South Korea ; Cha, Sangwon/C-6917-2008; Kim, Sunghwan/HKN-9812-2023 57218223095; 57218220414; 57202230755; 7006298844; 16052094600; 58839420600; 57203772967 donghwikim@kiost.ac.kr;sunghwank@knu.ac.kr; JOURNAL OF MASS SPECTROMETRY J MASS SPECTROM 1076-5174 1096-9888 56 4 SCIE BIOCHEMICAL RESEARCH METHODS;CHEMISTRY, ANALYTICAL;SPECTROSCOPY 2021 2.394 45.4 0.17 2025-07-30 1 2 corona discharge; dielectric constant; dielectric layer; mass spectrometry; paper spray chemical ionization MASS-SPECTROMETRY; REAL-TIME; MOLECULAR-IONS; DESORPTION; PLASMA; OPTIMIZATION; GENERATION; SAMPLES; TISSUE; DRUGS corona discharge; dielectric constant; dielectric layer; mass spectrometry; paper spray chemical ionization Electric corona; Ionization; Mass spectrometry; Petroleum analysis; Polyethylenes; 2 butanol; 2 propanol; alcohol; chlorobenzene; dichloromethane; hexane; petroleum; phenanthrene; solvent; toluene; Applied potentials; Charge accumulation; Chemical ionization; Corona discharges; Critical threshold; Non-polar solvents; Sensitive method; Triangular shapes; Article; dielectric constant; ionization; mass spectrometry; paper chromatography; paper spray chemical ionization; photography; priority journal; surface property; Solvents English 2021 2021-04 10.1002/jms.4602 바로가기 바로가기 바로가기 바로가기
Article Ruled Real Hypersurfaces in the Complex Quadric First we introduce the notions of eta-parallel and eta-commuting shape operator for real hypersurfaces in the complex quadric Q(m) = SOm+2/SOmSO2. Next we give a complete classification of real hypersurfaces in the complex quadric Qm with such kind of shape operators. By virtue of this classification we give a new characterization of ruled real hypersurface foliated by complex totally geodesic hyperplanes Q(m-1) in Q(m) whose unit normal vector field in Q(m) is U-principal. Kimura, Makoto; Lee, Hyunjin; Perez, Juan de Dios; Suh, Young Jin Ibaraki Univ, Dept Math, Mito, Ibaraki 3108512, Japan; Kyungpook Natl Univ, Res Inst Real & Complex Manifolds, Daegu 41566, South Korea; Univ Granada, Dept Geometry & Topol, Granada 18071, Spain; Kyungpook Natl Univ, Coll Nat Sci, Dept Math, Daegu 41566, South Korea; Kyungpook Natl Univ, Coll Nat Sci, Res Inst Real & Complex Manifolds, Daegu 41566, South Korea de Dios Perez, Juan/B-7768-2015 35549193300; 55706812200; 57205268627; 7202260479 makoto.kimura.geometry@vc.ibaraki.ac.jp;lhjibis@hanmail.net;jdperez@ugr.es;yjsuh@knu.ac.kr; JOURNAL OF GEOMETRIC ANALYSIS J GEOM ANAL 1050-6926 1559-002X 31 8 SCIE MATHEMATICS 2021 1.002 45.5 0.83 2025-07-30 5 4 eta-Parallel shape operator; U-Isotropic; U-Principal; Ruled real; hypersurface; Complex conjugation; Complex quadric SUBMANIFOLDS A-Isotropic; A-Principal; Complex conjugation; Complex quadric; Ruled real hypersurface; η-Parallel shape operator English 2021 2021-08 10.1007/s12220-020-00564-2 바로가기 바로가기 바로가기 바로가기
페이지 이동:

논문 데이터 용어 설명

용어 설명
WoS Web of Science. Clarivate Analytics에서 제공하는 학술 데이터베이스입니다. 해당 논문이 WoS에 수록되어 있는지 여부를 표시합니다 (○: 수록됨).
SCOPUS Elsevier에서 제공하는 세계 최대 규모의 초록 및 인용 데이터베이스입니다. 해당 논문이 SCOPUS에 수록되어 있는지 여부를 표시합니다 (○: 수록됨).
Document Type 문헌의 유형을 나타냅니다. Article(원저), Review(리뷰), Proceeding Paper(학회논문), Editorial Material(편집자료), Letter(레터) 등으로 분류됩니다.
Title 논문의 제목입니다.
Abstract 논문의 초록(요약)입니다. 연구의 목적, 방법, 결과, 결론을 간략히 요약한 내용입니다.
Authors 논문의 저자 목록입니다. 공동 저자가 여러 명인 경우 세미콜론(;)으로 구분됩니다.
Affiliation 저자들의 소속 기관 정보입니다. 대학, 연구소, 기업 등 저자가 소속된 기관명이 표시됩니다.
ResearcherID (WoS) Web of Science의 고유 연구자 식별번호입니다. 동명이인을 구분하고 연구자의 업적을 정확하게 추적할 수 있습니다.
AuthorsID (SCOPUS) SCOPUS의 고유 저자 식별번호입니다. 연구자의 모든 출판물을 추적하고 관리하는 데 사용됩니다.
Journal 논문이 게재된 학술지의 정식 명칭입니다.
JCR Abbreviation Journal Citation Reports에서 사용하는 저널의 공식 약어입니다. 저널을 간략하게 표기할 때 사용됩니다.
ISSN International Standard Serial Number. 국제표준연속간행물번호로, 인쇄본 저널에 부여되는 고유 식별번호입니다.
eISSN Electronic ISSN. 전자 버전 저널에 부여되는 고유 식별번호입니다.
Volume 저널의 권(Volume) 번호입니다. 보통 연도별로 하나의 권이 부여됩니다.
Issue 저널의 호(Issue) 번호입니다. 한 권 내에서 여러 호로 나누어 출판되는 경우가 많습니다.
WoS Edition Web of Science의 에디션입니다. SCIE(Science Citation Index Expanded), SSCI(Social Sciences Citation Index), AHCI(Arts & Humanities Citation Index) 등으로 구분됩니다.
WoS Category Web of Science의 주제 분류 카테고리입니다. 저널과 논문이 속한 학문 분야를 나타냅니다.
JCR Year 해당 저널의 JCR(Journal Citation Reports) 지표가 산출된 연도입니다.
IF (Impact Factor) 저널 영향력 지수. 최근 2년간 발표된 논문이 해당 연도에 평균적으로 인용된 횟수를 나타냅니다. 저널의 학술적 영향력을 나타내는 대표적인 지표입니다.
JCR (%) 해당 카테고리에서 저널이 위치하는 상위 백분율입니다. 값이 낮을수록 우수한 저널임을 의미합니다 (예: 5%는 상위 5%를 의미).
FWCI Field-Weighted Citation Impact. 분야별 가중 인용 영향력 지수입니다. 논문이 받은 인용을 동일 분야, 동일 연도, 동일 문헌 유형의 평균과 비교한 값입니다. 1.0이 평균이며, 1.0보다 높으면 평균 이상의 인용을 받았음을 의미합니다.
FWCI UpdateDate FWCI 값이 마지막으로 업데이트된 날짜입니다. FWCI는 인용이 누적됨에 따라 주기적으로 업데이트됩니다.
WOS Citation Web of Science에서 집계된 해당 논문의 총 인용 횟수입니다.
SCOPUS Citation SCOPUS에서 집계된 해당 논문의 총 인용 횟수입니다.
Keywords (WoS) 저자가 논문에서 직접 지정한 키워드입니다. Web of Science에 등록된 저자 키워드 목록입니다.
KeywordsPlus (WoS) Web of Science에서 자동으로 추출한 추가 키워드입니다. 논문의 참고문헌 제목에서 자주 등장하는 단어들로 생성됩니다.
Keywords (SCOPUS) 저자가 논문에서 직접 지정한 키워드입니다. SCOPUS에 등록된 저자 키워드 목록입니다.
KeywordsPlus (SCOPUS) SCOPUS에서 자동으로 추출하거나 추가한 색인 키워드입니다.
Language 논문이 작성된 언어입니다. 대부분 English이며, 그 외 다양한 언어로 작성된 논문이 포함될 수 있습니다.
Publication Year 논문이 출판된 연도입니다.
Publication Date 논문의 정확한 출판 날짜입니다 (년-월-일 형식).
DOI Digital Object Identifier. 디지털 객체 식별자로, 논문을 고유하게 식별하는 영구적인 식별번호입니다. 이를 통해 논문의 온라인 위치를 찾을 수 있습니다.